FHA
CABA icon

Flagship Harbor Advisors’s Cabaletta Bio CABA Stock Holding History

Flagship Harbor Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$2.19K – 928
2025
Q4 		$2.19K Buy
+1,000
New +$2.48K ﹤0.01% 1840

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Flagship Harbor Advisors's CABA Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 1,000 shares — an estimated $2.19K sold.

Flagship Harbor Advisors first reported a position in CABA in Q4 2025 and held it in 1 quarter. The position peaked at $2.19K in Q4 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 1,000 Cabaletta Bio shares in Q1 2026, an estimated $2.19K.
  • Flagship Harbor Advisors first reported a position in Cabaletta Bio in Q4 2025 and held it in 1 quarter.
  • Flagship Harbor Advisors's Cabaletta Bio position peaked at $2.19K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.